Met Life Investment Management, LLC Pliant Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 36,788 shares of PLRX stock, worth $49,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,788
Previous 32,863 11.94%
Holding current value
$49,663
Previous $368,000 31.52%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$10.55 - $15.7 $41,408 - $61,622
3,925 Added 11.94%
36,788 $484,000
Q2 2024

Aug 13, 2024
BUY
$10.58 - $15.61 $32,258 - $47,594
3,049 Added 10.23%
32,863 $353,000
Q1 2024

May 14, 2024
BUY
$14.14 - $19.59 $421,569 - $584,056
29,814 New
29,814 $444,000
Q3 2023

May 09, 2024
BUY
$14.58 - $20.15 $434,688 - $600,752
29,814 New
29,814 $516,000
Q2 2023

Apr 29, 2024
BUY
$18.12 - $30.56 $540,229 - $911,115
29,814 New
29,814 $540,000
Q2 2023

Aug 10, 2023
BUY
$18.12 - $30.56 $540,229 - $911,115
29,814 New
29,814 $540,000
Q1 2022

May 12, 2022
SELL
$7.01 - $14.1 $66,651 - $134,062
-9,508 Closed
0 $0
Q4 2021

Jun 21, 2023
BUY
$12.27 - $18.26 $116,663 - $173,616
9,508 New
9,508 $128,000
Q3 2021

Jun 21, 2023
BUY
$16.48 - $28.98 $156,691 - $275,541
9,508 New
9,508 $160,000
Q2 2021

Jun 21, 2023
BUY
$28.05 - $37.69 $266,699 - $358,356
9,508 New
9,508 $276,000
Q1 2021

May 17, 2024
SELL
$24.52 - $40.23 $497,903 - $816,910
-20,306 Reduced 68.11%
9,508 $373,000
Q1 2021

Jun 26, 2023
BUY
$24.52 - $40.23 $233,136 - $382,506
9,508 New
9,508 $374 Million
Q1 2021

Mar 22, 2023
BUY
$24.52 - $40.23 $113,601 - $186,385
4,633 Added 95.04%
9,508 $373,000
Q1 2021

May 14, 2021
BUY
$24.52 - $40.23 $113,601 - $186,385
4,633 Added 95.04%
9,508 $374,000
Q4 2020

Jun 22, 2023
BUY
$19.89 - $32.99 $96,963 - $160,826
4,875 New
4,875 $110,000
Q3 2020

May 24, 2024
SELL
$21.54 - $29.53 $537,186 - $736,448
-24,939 Reduced 83.65%
4,875 $110 Million
Q3 2020

Jun 26, 2023
BUY
$21.54 - $29.53 $105,007 - $143,958
4,875 New
4,875 $110,000
Q3 2020

Mar 22, 2023
BUY
$21.54 - $29.53 $105,007 - $143,958
4,875 New
4,875 $110,000
Q3 2020

Nov 13, 2020
BUY
$21.54 - $29.53 $105,007 - $143,958
4,875 New
4,875 $110,000

Others Institutions Holding PLRX

# of Institutions
175
Shares Held
64.8M
Call Options Held
228K
Put Options Held
772K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $65.7M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email